TransMedics (TMDX) EBIT Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | -51.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.55% |
| Dec 31, 2025 | 146.10% |
| Sep 30, 2025 | 493.93% |
| Jun 30, 2025 | 192.35% |
| Mar 31, 2025 | 120.94% |
| Dec 31, 2024 | 232.08% |
| Sep 30, 2024 | 113.85% |
| Jun 30, 2024 | 1,480.57% |
| Mar 31, 2024 | 694.59% |
| Dec 31, 2023 | 138.40% |
| Sep 30, 2023 | -411.09% |
| Jun 30, 2023 | 90.70% |
| Mar 31, 2023 | 77.70% |
| Dec 31, 2022 | 40.16% |
| Sep 30, 2022 | 52.72% |
| Jun 30, 2022 | 1.25% |
| Mar 31, 2022 | -43.98% |
| Dec 31, 2021 | -92.13% |
| Sep 30, 2021 | -154.34% |
| Jun 30, 2021 | -25.53% |
| Mar 31, 2021 | 18.83% |
| Dec 31, 2020 | 32.18% |
| Sep 30, 2020 | 36.34% |
| Jun 30, 2020 | -2.02% |
| Mar 31, 2020 | -34.47% |
| Dec 28, 2019 | -36.68% |
| Sep 28, 2019 | -83.85% |
| Jun 29, 2019 | -49.44% |
| Mar 30, 2019 | -24.70% |